GLAVAHCS, Los Angeles, California, USA.
Antimicrob Agents Chemother. 2013 Aug;57(8):3767-74. doi: 10.1128/AAC.00386-13. Epub 2013 May 28.
Two multidrug-resistant Bacteroides fragilis clinical isolates contain and express a novel nim gene, nimJ, that is not recognized by the "universal" nim primers and can confer increased resistance to metronidazole when introduced into a susceptible strain on a multicopy plasmid. HMW615, an appendiceal isolate, contains at least two copies of nimJ on its genome, while HMW616, an isolate from a patient with sepsis, contains one genomic copy of nimJ. B. fragilis NimJ is phylogenetically closer to Prevotella baroniae NimI and Clostridium botulinum NimA than to the other known Bacteroides Nim proteins. The predicted protein structure of NimJ, based on fold recognition analysis, is consistent with the crystal structures derived for known Nim proteins, and specific amino acid residues important for substrate binding in the active site are conserved. This study demonstrates that the "universal" nim primers will not detect all nim genes with the ability to confer metronidazole resistance, but nimJ alone cannot account for the very high metronidazole MICs of these resistant clinical isolates.
两株多药耐药脆弱拟杆菌临床分离株含有并表达一种新型 nim 基因 nimJ,该基因不能被“通用” nim 引物识别,当它被引入敏感菌株的多拷贝质粒中时,可赋予对甲硝唑的增加抗性。HMW615 是阑尾分离株,其基因组中至少含有两个 nimJ 拷贝,而 HMW616 是来自脓毒症患者的分离株,含有一个基因组拷贝的 nimJ。脆弱拟杆菌 NimJ 在系统发育上与 prevotella baroniae nimI 和梭状芽胞杆菌 nimA 比其他已知的拟杆菌 Nim 蛋白更接近。基于折叠识别分析预测的 NimJ 蛋白结构与已知 Nim 蛋白的晶体结构一致,并且在活性位点中对底物结合很重要的特定氨基酸残基保守。这项研究表明,“通用”nim 引物不能检测所有具有赋予甲硝唑抗性能力的 nim 基因,但 nimJ 本身不能解释这些耐药临床分离株非常高的甲硝唑 MIC 值。